Xenon Pharmaceuticals Inc. (XENE)
NASDAQ
Xenon Pharmaceuticals Inc. PS Ratio 2014–2026
Current and historical P/S ratio for Xenon Pharmaceuticals Inc. (XENE): market cap divided by trailing twelve-month revenue. As of March 31, 2026 it is 677.22.
From: 03/31/2015To: 03/31/2026
Stock Price
TTM Revenue
PS Ratio
Xenon Pharmaceuticals Inc. PS Ratio — FAQ
Xenon Pharmaceuticals Inc. (XENE) ps ratio over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XENE's ps ratio history?
The chart and table above show Xenon Pharmaceuticals Inc.'s ps ratio by year and by quarter, including the growth rate.